- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lupin RnD facility in Pune bags LEED Platinum Certification
Mumbai: Global pharma major Lupin Limited has announced that its R&D facility at Lupin Research Park, Pune has been awarded the LEED Platinum Certification for Operations and Maintenance by the U.S. Green Building Council (USGBC).
The facility was designed to be a LEED Platinum building and inaugurated in 2017 and has retained the highest level of certification after 7 years of operations.
"This recognition makes Lupin one of the first Indian pharmaceutical companies to achieve this distinguished milestone," the Company claims.
Commenting on this achievement, Nilesh Gupta, Managing Director, Lupin, said, “We are delighted to be awarded the prestigious LEED Platinum Certification for our Research facility at Lupin Research Park, a significant landmark for us as well as the Indian pharma sector. This accomplishment is a testament to our team’s commitment to innovation, sustainability and creating a lasting positive impact on the environment.”
According to the release, Lupin prioritizes sustainability across its operations, spearheading initiatives that reduce dependency on fossil fuels and enhance resource efficiency. At the Pune R&D facility, these efforts by the Company have resulted in significant environmental benefits including:
- Energy Efficiency and Renewable Energy Adoption: The facility utilizes green energy sources through a mix of on-site and off-site initiatives.
- Water Conservation Measures: Advanced water efficiency strategies have reduced the facility’s reliance on external sources, conserving a critical natural resource.
- Sustainable Waste Management: Adhering to the principles of reduce, reuse, recycle and repurpose, the Pune facility achieves near-zero waste to landfill, aligning with LEED’s global sustainability standards.
- Healthy Workspaces: The facility’s design and operational practices ensure superior indoor air quality, creating a healthy and comfortable environment for its occupants.
The U.S. Green Building Council is a non-profit trade organization that promotes sustainability in how buildings are designed, built and operated. The LEED certification program was developed to provide property owners and operators with strategies for improving the performance of buildings through energy savings, water efficiency, indoor environmental quality, stewardship of resources and other measures. By using less energy, LEED-certified buildings save money, reduce greenhouse gas emissions, and contribute to a healthier environment for residents, workers and the larger community.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751